XENE / Xenon Pharmaceuticals Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Xenon Pharmaceuticals Inc.
US ˙ NasdaqGM ˙ CA98420N1050

Jumlah Saham Beredar 77,105,799 shares
Saham Orang Dalam1,060,395 shares
Kepemilikan oleh Orang Dalam1.38 %
Orang Dalam Sejati38
Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

-1 ( )

9883 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

5172 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Xenon Pharmaceuticals Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Sherry Aulin Chief Financial Officer - [O] 0 0
Ernesto Aycardi-fonseca Chief Medical Officer - [O] 0 0
Mohammad Azab Director - [D] 74,225 74,225
Biotechnology Value Fund Ii Lp - 59,464 59,464
Biotechnology Value Fund L P - 59,464 59,464
Bvf Inc/il 10% Owner - [10%] 59,464 59,464
Bvf Partners L P/il 10% Owner - [10%] 59,464 59,464
BVF Partners OS Ltd. - 59,464 59,464
Biotechnology Value Trading Fund OS LP - 59,464 59,464
Gary Bridger 5,144
Cohen Charles J. VP, Biology - [O] 6,550 6,550
Corraini Karen G. See Remarks - [O] 4,114 4,114
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Gillian Cannon Director - [D] 0 0
Darren S Cline Chief Commercial Officer - [O] 0 0
Clarissa Desjardins Director - [D] 0 0
Andrea DiFabio Chief Legal Officer - [O] 0 0
Empfield James R. EVP, Drug Discovery - [O] 10,000 10,000
Johnston L Evans Director - [D] 444,655 444,655
Steven Gannon Director - [D] 7,141 7,141
Garofalo Elizabeth A. Director - [D] 0 0
Goldberg Y. Paul VP of Clinical Development - [O] 6,000 6,000
Gover Justin D. Director - [D] 0 0
Frank A Holler Director - [D] 143,653 143,653
Michael R Hayden Director - [D] 116,206 116,206
Christopher John Kenney Chief Medical Officer - [O] 0 0
Orang Dalam Rata-rata Keuntungan (%) Saham
Dimiliki
Terbagi
Disesuaikan
Mark N Lampert 10% Owner - [10%] 59,464 59,464
Ian Mortimer PRESIDENT & CEO, Director - [D] [O] 31,302 31,302
Associates, LLP MX 10% Owner - [10%] 0 0
Patrick Machado Director - [D] 0 0
Gary Patou Director - [D] 23,573 23,573
Pimstone Simon N. Director - [D] 6,000 6,000
Sherrington Robin EVP, Strategy & Innovation - [O] 8,398 8,398
Richard H Scheller Director - [D] 7,000 7,000
Stein Evan A. Director - [D] 4,172 4,172
Dawn Svoronos Director - [D] 25,000 25,000
Michael M Tarnow Director - [D] 77,942 77,942
Seggern Christopher Von Chief Commercial Officer - [O] 4,000 4,000
Raymond Winquist Head, Translational Research - [O] 1,000 1,000

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di XENE / Xenon Pharmaceuticals Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2022-01-21 KENNEY CHRISTOPHER JOHN 700 28.8100 700 28.8100 20,167 215 39.8200 7,707 38.22
2021-12-06 Von Seggern Christopher 4,000 24.4000 4,000 24.4000 97,600
2017-11-15 AZAB MOHAMMAD 15,000 2.2187 15,000 2.2187 33,280
2017-09-22 AZAB MOHAMMAD 8,000 2.9500 8,000 2.9500 23,600
2017-09-21 AZAB MOHAMMAD 2,000 2.9500 2,000 2.9500 5,900
2017-08-18 AZAB MOHAMMAD 6,312 2.8995 6,312 2.8995 18,302
2017-08-18 WINQUIST RAYMOND 1,000 2.9950 1,000 2.9950 2,995
2017-08-17 AZAB MOHAMMAD 23 2.6500 23 2.6500 61
2017-08-15 EMPFIELD JAMES R. 10,000 2.4824 10,000 2.4824 24,824

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di XENE / Xenon Pharmaceuticals Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2025-06-05 GANNON STEVEN 3 30.4800 3 30.4800 91 50 30.3000 -0 -0.11
2024-12-18 AULIN SHERRY 7,199 41.2300 7,199 41.2300 296,815
2024-12-18 AULIN SHERRY 11,510 41.1900 11,510 41.1900 474,097
2024-11-22 PATOU GARY 2,851 41.1100 2,851 41.1100 117,205
2024-11-22 PATOU GARY 2,040 41.0500 2,040 41.0500 83,742
2024-03-08 GAROFALO ELIZABETH A. 2,092 45.6900 2,092 45.6900 95,583
2024-03-07 ROBIN SHERRINGTON 1,019 46.1500 1,019 46.1500 47,027
2024-03-07 ROBIN SHERRINGTON 6,118 46.3000 6,118 46.3000 283,263
2024-03-07 GANNON STEVEN 1,000 46.4500 1,000 46.4500 46,450

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

XENE / Xenon Pharmaceuticals Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas
Tanggal
Perdagangan
Tanggal
Formulir Orang Dalam Ticker Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Unit
Diubah
Nilai
Diubah (1 ribu)
Sisa
Pilihan
Sisa
Saham
2025-06-24 3 Cline Darren S XENE No securities are beneficially owned. D 0
2025-06-06 2025-06-05 4 GANNON STEVEN XENE Common Shares S - Sale D 30.4800 -3 -0 7,141
2025-05-16 2025-05-14 4 GANNON STEVEN XENE Common Shares M - Exercise D 12.5700 5,144 65 7,144
2025-01-27 2025-01-27 4 MORTIMER IAN XENE Common Shares S - Sale D 41.0700 -1,149 -47 31,302
2025-01-27 2025-01-27 4 MORTIMER IAN XENE Common Shares M - Exercise D 17.7600 1,149 20 32,451
2025-01-27 2025-01-27 4 MORTIMER IAN XENE Common Shares S - Sale D 40.4600 -15,166 -614 31,302
2025-01-27 2025-01-27 4 MORTIMER IAN XENE Common Shares M - Exercise D 17.7600 15,166 269 46,468
2025-01-27 2025-01-24 4 MORTIMER IAN XENE Common Shares S - Sale D 40.2000 -22,468 -903 31,302
2025-01-27 2025-01-24 4 MORTIMER IAN XENE Common Shares M - Exercise D 17.7600 22,468 399 53,770
2025-01-27 2025-01-23 4 MORTIMER IAN XENE Common Shares S - Sale D 40.0800 -16,217 -650 31,302
2025-01-27 2025-01-23 4 MORTIMER IAN XENE Common Shares M - Exercise D 17.7600 16,217 288 47,519
2024-12-19 2024-12-18 4 AULIN SHERRY XENE Common Shares S - Sale D 41.1900 -11,510 -474 0
2024-12-19 2024-12-18 4 AULIN SHERRY XENE Common Shares F - Taxes D 41.2800 -4,490 -185 11,510
2024-12-19 2024-12-18 4 AULIN SHERRY XENE Common Shares M - Exercise D 11.5800 16,000 185 16,000
2024-12-19 2024-12-18 4 AULIN SHERRY XENE Common Shares S - Sale D 41.2300 -7,199 -297 0
2024-12-19 2024-12-18 4 AULIN SHERRY XENE Common Shares F - Taxes D 41.2800 -2,135 -88 7,199
2024-12-19 2024-12-18 4 AULIN SHERRY XENE Common Shares M - Exercise D 9.4400 9,334 88 9,334
2024-11-22 2024-11-22 4 PATOU GARY XENE Common Shares S - Sale D 41.0500 -2,040 -84 23,573
2024-11-22 2024-11-22 4 PATOU GARY XENE Common Shares F - Taxes D 39.8000 -1,046 -42 25,613
2024-11-22 2024-11-22 4 PATOU GARY XENE Common Shares M - Exercise D 13.4800 3,086 42 26,659
2024-11-22 2024-11-22 4 PATOU GARY XENE Common Shares S - Sale D 41.1100 -2,851 -117 23,573
2024-11-22 2024-11-22 4 PATOU GARY XENE Common Shares F - Taxes D 39.8000 -649 -26 26,424
2024-11-22 2024-11-22 4 PATOU GARY XENE Common Shares M - Exercise D 7.3800 3,500 26 27,073
2024-03-11 2024-03-08 4 GAROFALO ELIZABETH A. XENE Common Shares S - Sale D 45.6900 -2,092 -96 0
2024-03-11 2024-03-08 4 GAROFALO ELIZABETH A. XENE Common Shares F - Taxes D 46.1600 -1,408 -65 2,092
2024-03-11 2024-03-08 4 GAROFALO ELIZABETH A. XENE Common Shares M - Exercise D 18.5600 3,500 65 3,500
2024-03-08 2024-03-07 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 46.3000 -6,118 -283 8,398
2024-03-08 2024-03-07 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 46.1500 -1,019 -47 14,516
2024-03-08 2024-03-07 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 45.9600 -1,289 -59 15,535
2024-03-08 2024-03-07 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 9.8500 7,407 73 16,824
2024-03-08 2024-03-07 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 45.9600 -215 -10 9,417
2024-03-08 2024-03-07 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 9.8500 1,234 12 9,632
2024-03-08 2024-03-07 4 GANNON STEVEN XENE Common Shares S - Sale D 46.2012 -2,000 -92 2,000
2024-03-08 2024-03-07 4 GANNON STEVEN XENE Common Shares S - Sale D 46.3025 -5,000 -232 4,000
2024-03-08 2024-03-07 4 GANNON STEVEN XENE Common Shares S - Sale D 46.2500 -5,000 -231 9,000
2024-03-08 2024-03-07 4 GANNON STEVEN XENE Common Shares S - Sale D 46.4500 -1,000 -46 14,000
2024-01-02 2023-12-29 4 ROBIN SHERRINGTON XENE Common Shares J - Other D -8,398 8,398
2023-12-20 2023-12-19 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 9.8500 3,497 34 74,225
2023-12-20 2023-12-19 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 9.8500 823 8 70,728
2023-12-15 2023-12-14 4/A PATOU GARY See Note XENE Common Shares S - Sale I 41.0500 -7,598 -312 4,902
2023-12-15 2023-12-13 4 PATOU GARY See Note XENE Common Shares S - Sale I 41.0500 -7,598 -312 4,902
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares S - Sale D 39.8400 -3,977 -158 23,573
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares F - Taxes D 39.6800 -1,167 -46 27,550
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares M - Exercise D 9.0000 5,144 46 28,717
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares S - Sale D 39.1000 -2,303 -90 23,573
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares F - Taxes D 39.6800 -577 -23 25,876
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares M - Exercise D 9.8500 2,880 28 26,453
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares S - Sale D 38.9400 -5,100 -199 23,573
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares F - Taxes D 39.6800 -1,278 -51 28,673
2023-12-15 2023-12-13 4 PATOU GARY XENE Common Shares M - Exercise D 9.8500 6,378 63 29,951
2023-08-24 2023-08-24 4 Svoronos Dawn XENE Common Shares S - Sale D 38.7000 -25,000 -968 25,000
2023-08-10 3 Gover Justin D. XENE No securities are beneficially owned. D 0
2023-08-10 3 Cannon Gillian XENE No securities are beneficially owned. D 0
2023-06-01 2023-06-01 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.7800 -24,255 -941 6,000
2023-06-01 2023-06-01 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 38.5300 -20,745 -799 30,255
2023-06-01 2023-06-01 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 17.7600 45,000 799 51,000
2023-06-01 2023-06-01 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.9700 -7,458 -291 6,000
2023-06-01 2023-06-01 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 38.5300 -1,860 -72 13,458
2023-06-01 2023-06-01 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 7.6900 9,318 72 15,318
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.6900 -26,856 -1,039 6,000
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 38.3700 -23,144 -888 32,856
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 17.7600 50,000 888 56,000
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.8100 -23,670 -919 6,000
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 38.3700 -6,165 -237 29,670
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 9.8500 29,835 294 35,835
2023-06-01 2023-05-31 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.5300 -12,000 -462 6,000
2023-06-01 2023-05-30 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 39.9000 -19,000 -758 18,000
2023-06-01 2023-05-30 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.6300 -18,006 -696 37,000
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares S - Sale D 41.4900 -1,407 -58 31,302
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares F - Taxes D 41.8400 -1,171 -49 32,709
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares M - Exercise D 9.8500 6,172 61 33,880
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares S - Sale D 41.3700 -13,179 -545 27,708
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares F - Taxes D 41.8400 -3,902 -163 40,887
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares M - Exercise D 9.8500 20,576 203 44,789
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares S - Sale D 41.4400 -17,069 -707 24,213
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares F - Taxes D 41.8400 -7,310 -306 41,282
2023-05-26 2023-05-24 4 MORTIMER IAN XENE Common Shares M - Exercise D 9.4400 42,592 402 48,592
2023-03-24 2023-03-24 4 KENNEY CHRISTOPHER JOHN XENE Common Shares S - Sale D 35.0100 -700 -25 0
2023-03-09 2023-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 36.9400 -8,242 -304 55,006
2023-03-09 2023-03-07 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 37.1300 -1,618 -60 63,248
2023-03-09 2023-03-07 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 2.5900 30,864 80 64,866
2023-03-09 2023-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 37.0100 -10,990 -407 34,002
2023-03-09 2023-03-07 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 37.1300 -2,160 -80 44,992
2023-03-09 2023-03-07 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 2.6800 41,152 110 47,152
2022-12-13 2022-12-12 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 2.6800 3,086 8 69,905
2022-11-28 2022-11-25 4 PATOU GARY XENE Common Shares S - Sale D 34.7911 -1,937 -67 23,573
2022-11-28 2022-11-25 4 PATOU GARY XENE Common Shares F - Taxes D 34.3700 -120 -4 25,510
2022-11-28 2022-11-25 4 PATOU GARY XENE Common Shares M - Exercise D 2.6800 2,057 6 25,630
2022-11-28 2022-11-23 4 PATOU GARY XENE Common Shares S - Sale D 34.3265 -2,057 -71 23,573
2022-11-09 3 DiFabio Andrea XENE No securities are beneficially owned. D 0
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares S - Sale D 39.5700 -15,355 -608 0
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares F - Taxes D 39.5300 -3,293 -130 15,355
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares M - Exercise D 4.7500 6,511 31 18,648
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares M - Exercise D 3.1000 2,292 7 12,137
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares M - Exercise D 8.4000 813 7 9,845
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares M - Exercise D 7.4900 32 0 9,032
2022-09-07 2022-09-02 4 AULIN SHERRY XENE Common Shares M - Exercise D 9.4400 9,000 85 9,000
2022-09-02 2022-09-01 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 38.8000 -8,776 -341 16,796
2022-09-02 2022-09-01 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 38.0300 -35,103 -1,335 25,572
2022-09-02 2022-09-01 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 38.8100 -6,121 -238 60,675
2022-09-02 2022-09-01 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 4.7500 50,000 238 66,796
2022-09-02 2022-08-31 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 38.5700 -21,352 -824 16,796
2022-09-02 2022-08-31 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 37.8600 -1,572 -60 38,148
2022-09-02 2022-08-31 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 4.7500 5,000 24 39,720
2022-09-02 2022-08-31 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 2.6700 17,488 47 34,720
2022-08-16 2022-08-12 4 EMPFIELD JAMES R. XENE Common Shares S - Sale D 38.6800 -21,875 -846 10,000
2022-08-16 2022-08-12 4 EMPFIELD JAMES R. XENE Common Shares S - Sale D 38.0800 -35,868 -1,366 31,875
2022-08-16 2022-08-12 4 EMPFIELD JAMES R. XENE Common Shares F - Taxes D 38.0200 -7,257 -276 67,743
2022-08-16 2022-08-12 4 EMPFIELD JAMES R. XENE Common Shares M - Exercise D 4.7500 45,000 214 75,000
2022-08-16 2022-08-12 4 EMPFIELD JAMES R. XENE Common Shares M - Exercise D 3.1000 20,000 62 30,000
2022-08-16 2022-08-16 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.8700 -20,000 -777 6,000
2022-08-16 2022-08-16 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.2900 -32,058 -1,228 26,000
2022-08-16 2022-08-15 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 37.7600 -33,942 -1,282 58,058
2022-08-16 2022-08-12 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 39.1500 -1,000 -39 92,000
2022-08-16 2022-08-12 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 38.6000 -47,000 -1,814 93,000
2022-08-16 2022-08-12 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 37.9100 -43,135 -1,635 140,000
2022-03-14 2022-03-10 4 Von Seggern Christopher XENE Stock Option (Right to Buy) A - Award D 30.01 100,000 100,000
2022-03-14 2022-03-10 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 30.01 75,000 75,000
2022-03-14 2022-03-10 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 30.01 25,000 25,000
2022-03-14 2022-03-10 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 30.01 400,000 400,000
2022-03-14 2022-03-10 4 KENNEY CHRISTOPHER JOHN XENE Stock Option (Right to Buy) A - Award D 30.01 125,000 125,000
2022-03-14 2022-03-10 4 AULIN SHERRY XENE Stock Option (Right to Buy) A - Award D 30.01 125,000 125,000
2022-03-14 2022-03-10 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 30.01 65,000 65,000
2022-03-08 2022-03-08 4/A PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.8000 -2,500 -77 193,135
2022-03-08 2022-03-08 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.5000 -2,500 -76 183,135
2022-03-08 2022-03-08 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.5500 -2,500 -76 185,635
2022-03-08 2022-03-08 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.2000 -2,500 -76 188,135
2022-03-08 2022-03-08 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.1000 -2,500 -75 190,635
2022-03-08 2022-03-08 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 3.8000 -2,500 -10 193,135
2022-03-08 2022-03-08 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.6000 -2,051 -63 195,635
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.67 -20,576 0
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.5500 -2,500 -76 197,686
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.5000 -7,500 -229 200,186
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.5200 -2,500 -76 207,686
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.4400 -4,516 -137 210,186
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.4500 -4,516 -138 214,702
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.4900 -4,517 -138 219,218
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.6000 -5,037 -154 223,735
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 30.2300 -1,990 -60 228,772
2022-03-08 2022-03-07 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.6700 20,576 76 230,762
2022-03-08 2022-03-04 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.67 -10,288 0
2022-03-08 2022-03-04 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.5600 -4,793 -146 210,186
2022-03-08 2022-03-04 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 30.6600 -4,532 -139 214,979
2022-03-08 2022-03-04 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 31.4200 -963 -30 219,511
2022-03-08 2022-03-04 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.6700 10,288 38 220,474
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.67 -6,172 0
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.67 -1,234 0
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 30.2300 -5,000 -151 17,232
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 31.0500 -5,000 -155 22,232
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 30.1500 -5,000 -151 27,232
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 30.5600 -6,710 -205 32,232
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.6700 6,172 23 38,942
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 31.4200 -696 -22 32,770
2022-03-08 2022-03-04 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.6700 1,234 5 33,466
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) M - Exercise D 6.76 -40,000 0
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) M - Exercise D 8.40 -2,500 0
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Common Shares S - Sale D 30.5400 -31,048 -948 10,000
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Common Shares S - Sale D 30.6200 -1,805 -55 41,048
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Common Shares F - Taxes D 30.2300 -8,952 -271 42,853
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Common Shares M - Exercise D 6.7600 40,000 270 51,805
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Common Shares F - Taxes D 30.2300 -695 -21 11,805
2022-03-08 2022-03-07 4 EMPFIELD JAMES R. XENE Common Shares M - Exercise D 8.4000 2,500 21 12,500
2022-03-08 2022-03-04 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) M - Exercise D 8.40 -25,000 0
2022-03-08 2022-03-04 4 EMPFIELD JAMES R. XENE Common Shares S - Sale D 30.7900 -18,315 -564 10,000
2022-03-08 2022-03-04 4 EMPFIELD JAMES R. XENE Common Shares F - Taxes D 31.4200 -6,685 -210 28,315
2022-03-08 2022-03-04 4 EMPFIELD JAMES R. XENE Common Shares M - Exercise D 8.4000 25,000 210 35,000
2022-01-21 2022-01-21 4 KENNEY CHRISTOPHER JOHN XENE Common Shares P - Purchase D 28.8100 700 20 700
2021-12-17 2021-12-15 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 3.67 -3,086 0
2021-12-17 2021-12-15 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 3.6700 3,086 11 66,819
2021-12-10 2021-12-08 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 3.67 -2,057 0
2021-12-10 2021-12-08 4 PATOU GARY XENE Common Shares M - Exercise D 3.6700 2,057 8 25,630
2021-12-07 2021-12-06 4 Von Seggern Christopher XENE Common Shares P - Purchase D 24.4000 4,000 98 4,000
2021-11-16 2021-11-15 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 31.3300 -17,557 -550 210,186
2021-08-25 3 KENNEY CHRISTOPHER JOHN XENE No securities are beneficially owned. D 0
2021-08-25 2021-08-23 4 KENNEY CHRISTOPHER JOHN XENE Stock Option (Right to Buy) A - Award D 16.64 150,000 150,000
2021-06-04 2021-06-03 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 18.56 10,000 10,000
2021-06-04 2021-03-17 4 PATOU GARY See Note XENE Common Shares L - Other I 19.4900 100 2 100
2021-06-03 2021-06-03 4 Svoronos Dawn XENE Stock Option (Right to Buy) A - Award D 18.56 10,000 10,000
2021-06-03 2021-06-03 4 Machado Patrick XENE Stock Option (Right to Buy) A - Award D 18.56 10,000 10,000
2021-06-03 2021-06-03 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 18.56 10,000 10,000
2021-06-03 2021-06-03 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 18.56 10,000 10,000
2021-06-03 2021-06-03 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 18.56 10,000 10,000
2021-06-03 2021-06-03 4 GAROFALO ELIZABETH A. XENE Stock Option (Right to Buy) A - Award D 18.56 20,000 20,000
2021-06-03 3 GAROFALO ELIZABETH A. XENE No securities are beneficially owned. D 0
2021-06-03 2021-06-03 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 18.56 125,000 125,000
2021-06-03 2021-06-03 4 AULIN SHERRY XENE Stock Option (Right to Buy) A - Award D 18.56 100,000 100,000
2021-06-03 3 AULIN SHERRY XENE No securities are beneficially owned. D 0
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.85 -13,374 0
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.76 -12,345 0
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 18.8100 -2,912 -55 32,232
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Common Shares S - Sale D 18.8100 -3,155 -59 35,144
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 18.9100 -2,192 -41 38,299
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.8500 13,374 51 40,491
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 18.9100 -2,024 -38 27,117
2021-06-01 2021-05-28 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.7600 12,345 46 29,141
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.76 -36,008 0
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.76 -3,086 0
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Common Shares S - Sale D 18.6800 -8,485 -158 143,653
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Common Shares S - Sale D 18.6900 -2,579 -48 152,138
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Common Shares F - Taxes D 18.8800 -5,911 -112 154,717
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.7600 36,008 135 160,628
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Common Shares F - Taxes D 18.8800 -507 -10 124,620
2021-06-01 2021-05-27 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.7600 3,086 12 125,127
2021-05-26 2021-05-24 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.76 -22,633 0
2021-05-26 2021-05-24 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 19.1700 -5,076 -97 227,743
2021-05-26 2021-05-24 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.7600 22,633 85 232,819
2021-05-20 2021-05-18 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.67 -5,144 0
2021-05-20 2021-05-18 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.67 -1,028 0
2021-05-20 2021-05-18 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.87 -2,057 0
2021-05-20 2021-05-18 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.6700 5,144 19 77,942
2021-05-20 2021-05-18 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.6700 1,028 4 72,798
2021-05-20 2021-05-18 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.8700 2,057 8 71,770
2021-05-20 2021-05-18 4 Hayden Michael R XENE Stock Option (Right to Buy) M - Exercise D 3.85 -3,500 0
2021-05-20 2021-05-18 4 Hayden Michael R XENE Common Shares M - Exercise D 3.8500 3,500 13 116,206
2021-03-15 2021-03-12 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 20.55 65,000 65,000
2021-03-15 2021-03-12 4 Von Seggern Christopher XENE Stock Option (Right to Buy) A - Award D 20.55 60,000 60,000
2021-03-15 2021-03-12 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 20.55 65,000 65,000
2021-03-15 2021-03-12 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 20.55 100,000 100,000
2021-03-15 2021-03-12 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 20.55 225,000 225,000
2021-02-18 2021-02-18 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 2.68 -30,864 0
2021-02-18 2021-02-18 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 3.67 -10,288 0
2021-02-18 2021-02-18 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 2.6800 30,864 83 92,076
2021-02-18 2021-02-18 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 3.6700 10,288 38 61,212
2021-02-18 2021-02-16 4 Hayden Michael R XENE Stock Option (Right to Buy) M - Exercise D 2.68 -5,144 0
2021-02-18 2021-02-16 4 Hayden Michael R XENE Common Shares M - Exercise D 2.6800 5,144 14 112,706
2020-12-15 2020-12-15 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 3.76 -3,086 0
2020-12-15 2020-12-15 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 3.7600 3,086 12 63,733
2020-11-05 2020-11-05 4 Machado Patrick XENE Stock Option (Right to Buy) A - Award D 11.85 20,000 20,000
2020-11-05 3 Machado Patrick XENE No securities are beneficially owned D 0
2020-10-29 2020-10-28 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.76 -5,144 0
2020-10-29 2020-10-28 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.76 -5,144 0
2020-10-29 2020-10-28 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -10,288 69,713
2020-10-29 2020-10-28 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.7600 5,144 19 80,001
2020-10-29 2020-10-28 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.7600 5,144 19 80,001
2020-10-29 2020-10-28 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 3.76 -2,057 0
2020-10-29 2020-10-28 4 PATOU GARY XENE Common Shares M - Exercise D 3.7600 2,057 8 23,573
2020-08-24 2020-08-20 4 PIMSTONE SIMON N. XENE Common Shares J - Other D -45,000 210,186
2020-08-17 2020-08-17 4 Von Seggern Christopher XENE Stock Option (Right to Buy) A - Award D 11.27 100,000 100,000
2020-08-17 3 Von Seggern Christopher XENE No securities are beneficially owned. D 0
2020-06-10 2020-06-09 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.52 -5,144 0
2020-06-10 2020-06-09 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.5200 5,144 18 69,713
2020-06-02 2020-06-01 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-06-01 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.56 -8,230 0
2020-06-02 2020-06-01 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 13.7000 -1,630 -22 16,796
2020-06-02 2020-06-01 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.5600 8,230 29 18,426
2020-06-02 2020-06-01 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 14.4300 -3,000 -43 255,186
2020-06-02 2020-05-29 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 13.9900 -5,000 -70 258,186
2020-06-02 2020-06-01 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-05-29 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.56 -3,086 0
2020-06-02 2020-05-29 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.5600 3,086 11 122,041
2020-06-02 2020-06-01 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-06-01 4 Desjardins Clarissa XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-06-01 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-06-01 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-06-01 4 Svoronos Dawn XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-06-02 2020-06-01 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 13.11 10,000 10,000
2020-05-28 2020-05-26 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.56 -6,172 0
2020-05-28 2020-05-26 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 14.9000 -1,108 -17 263,186
2020-05-28 2020-05-26 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.5600 6,172 22 264,294
2020-03-13 2020-03-12 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 11.58 65,000 65,000
2020-03-13 2020-03-12 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 11.58 65,000 65,000
2020-03-13 2020-03-12 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 11.58 145,000 145,000
2020-03-13 2020-03-12 4 AYCARDI-FONSECA ERNESTO XENE Stock Option (Right to Buy) A - Award D 11.58 65,000 65,000
2020-03-13 2020-03-12 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 11.58 280,000 280,000
2020-01-14 2020-01-13 4 Desjardins Clarissa XENE Stock Option (Right to Buy) A - Award D 16.42 25,000 25,000
2020-01-14 3 Desjardins Clarissa XENE No securities are beneficially owned D 0
2019-12-17 2019-12-16 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 3.56 -3,086 0
2019-12-17 2019-12-16 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 3.5600 3,086 11 60,647
2019-12-06 2019-12-04 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 3.56 -2,057 0
2019-12-06 2019-12-04 4 PATOU GARY XENE Common Shares M - Exercise D 3.5600 2,057 7 21,516
2019-11-22 2019-11-21 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.51 -2,057 0
2019-11-22 2019-11-21 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.56 -5,144 0
2019-11-22 2019-11-21 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -2,057 64,569
2019-11-22 2019-11-21 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.5100 2,057 7 66,626
2019-11-22 2019-11-21 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -5,144 64,569
2019-11-22 2019-11-21 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.5600 5,144 18 69,713
2019-09-24 2019-09-20 4 PIMSTONE SIMON N. XENE Common Shares S - Sale D 9.5100 -10,395 -99 258,122
2019-09-20 2019-09-20 4 HOLLER FRANK A XENE Common Shares S - Sale D 9.3900 -5,206 -49 118,955
2019-09-20 2019-09-19 4 HOLLER FRANK A XENE Common Shares S - Sale D 9.2700 -7,600 -70 124,161
2019-09-18 2019-09-16 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-16 4 SCHELLER RICHARD H XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-16 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 9.44 45,000 45,000
2019-09-18 2019-09-16 4 Svoronos Dawn XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.38 -12,345 0
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.07 -9,259 0
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.70 -36,008 0
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 9.4400 -3,692 -35 268,517
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.3800 12,345 42 272,209
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 9.4400 -2,769 -26 259,864
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.0700 9,259 28 262,633
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 9.4400 -10,769 -102 253,374
2019-09-18 2019-09-17 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.7000 36,008 133 264,143
2019-09-18 2019-09-16 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 9.44 280,000 280,000
2019-09-18 2019-09-18 4 HOLLER FRANK A XENE Common Shares S - Sale D 9.2800 -4,368 -41 131,761
2019-09-18 2019-09-17 4 HOLLER FRANK A XENE Common Shares S - Sale D 9.3200 -5,069 -47 136,129
2019-09-18 2019-09-16 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-16 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 9.44 135,000 135,000
2019-09-18 2019-09-16 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-16 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 9.44 40,000 40,000
2019-09-18 2019-09-16 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-16 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-18 2019-09-16 4 AYCARDI-FONSECA ERNESTO XENE Stock Option (Right to Buy) A - Award D 9.44 65,000 65,000
2019-09-17 2019-09-16 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 9.44 15,000 15,000
2019-09-17 2019-09-13 4 AZAB MOHAMMAD XENE Common Shares S - Sale D 9.3122 -23 -0 57,561
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.00 -25,720 0
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.07 -3,086 0
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.70 -3,086 0
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Common Shares F - Taxes D 9.3800 -7,781 -73 141,198
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.0000 25,720 77 148,979
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Common Shares F - Taxes D 9.3800 -934 -9 123,259
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Common Shares F - Taxes D 9.3800 -934 -9 123,259
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.0700 3,086 9 124,193
2019-09-13 2019-09-12 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.7000 3,086 11 122,041
2019-09-13 2019-09-12 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.07 -6,172 0
2019-09-13 2019-09-12 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 9.3800 -1,868 -18 10,196
2019-09-13 2019-09-12 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.0700 6,172 19 12,064
2019-05-23 2019-05-21 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.21 -2,057 0
2019-05-23 2019-05-21 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.2100 2,057 7 64,569
2019-03-20 2019-03-19 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 3.38 -20,576 0
2019-03-20 2019-03-19 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 3.3800 20,576 70 50,924
2019-03-12 2019-03-11 4 Hayden Michael R By Spouse XENE Common Shares G - Gift I 17,337 114,403
2019-03-12 2019-03-11 4 Hayden Michael R XENE Common Shares G - Gift D -24,045 107,562
2018-12-26 2018-12-21 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -5,000 62,512
2018-12-18 2018-12-14 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 3.07 -2,057 0
2018-12-18 2018-12-14 4 PATOU GARY XENE Common Shares M - Exercise D 3.0700 2,057 6 19,459
2018-12-13 2018-12-11 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) M - Exercise D 3.07 -4,115 0
2018-12-13 2018-12-11 4 COHEN CHARLES J. XENE Common Shares F - Taxes D 7.0000 -1,644 -12 6,550
2018-12-13 2018-12-11 4 COHEN CHARLES J. XENE Common Shares M - Exercise D 3.0700 4,115 13 8,194
2018-12-10 2018-12-06 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 3.07 -3,086 0
2018-12-10 2018-12-06 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 3.0700 3,086 9 57,584
2018-06-22 2018-06-21 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 3.70 -10,288 0
2018-06-22 2018-06-21 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 3.7000 10,288 38 54,498
2018-06-22 2018-06-21 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.07 -5,144 0
2018-06-22 2018-06-21 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.70 -5,144 0
2018-06-22 2018-06-21 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.66 -2,057 0
2018-06-22 2018-06-21 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.0700 5,144 16 67,512
2018-06-22 2018-06-21 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.6600 2,057 8 62,368
2018-06-22 2018-06-21 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.7000 5,144 19 60,311
2018-06-15 2018-06-14 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 3.70 -8,230 0
2018-06-15 2018-06-14 4 PATOU GARY XENE Common Shares F - Taxes D 8.3000 -2,856 -24 17,402
2018-06-15 2018-06-14 4 PATOU GARY XENE Common Shares M - Exercise D 3.7000 8,230 30 20,258
2018-06-05 2018-06-04 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 SCHELLER RICHARD H XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 Svoronos Dawn XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-06-05 2018-06-04 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 6.20 15,000 15,000
2018-03-29 2018-03-27 4 BVF PARTNERS L P/IL XENE Series 1 Preferred Shares J - Other D 238,000 238,000
2018-03-29 2018-03-27 4 BVF PARTNERS L P/IL XENE Series 1 Preferred Shares J - Other D 861,000 861,000
2018-03-29 2018-03-27 4 BVF PARTNERS L P/IL XENE Series 1 Preferred Shares J - Other D 1,338,000 1,338,000
2018-03-29 2018-03-27 4 BVF PARTNERS L P/IL XENE Common Shares, no par value per share J - Other D -238,000 59,464
2018-03-29 2018-03-27 4 BVF PARTNERS L P/IL XENE Common Shares, no par value per share J - Other D -861,000 216,694
2018-03-29 2018-03-27 4 BVF PARTNERS L P/IL XENE Common Shares, no par value per share J - Other D -1,338,000 336,468
2018-03-20 3 AYCARDI-FONSECA ERNESTO XENE No securities are beneficially owned D 0
2018-03-20 2018-03-19 4 AYCARDI-FONSECA ERNESTO XENE Stock Option (Right to Buy) A - Award D 4.65 50,000 50,000
2018-03-16 2018-03-14 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 3.77 -3,086 0
2018-03-16 2018-03-14 4 HOLLER FRANK A XENE Common Shares M - Exercise D 3.7700 3,086 12 118,955
2018-03-16 2018-03-15 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.77 -3,086 0
2018-03-16 2018-03-15 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 4.6250 -1,928 -9 5,892
2018-03-16 2018-03-15 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.7700 3,086 12 7,820
2018-03-14 2018-03-12 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.77 -10,288 0
2018-03-14 2018-03-12 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.7700 10,288 39 228,135
2018-03-13 2018-03-12 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 4.75 140,000 140,000
2018-03-13 2018-03-12 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 4.75 105,000 105,000
2018-03-13 2018-03-12 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 4.75 55,000 55,000
2018-03-13 2018-03-12 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 4.75 45,000 45,000
2018-03-13 2018-03-12 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) A - Award D 4.75 40,000 40,000
2018-03-01 2018-02-22 4 Hayden Michael R By Spouse XENE Common Shares G - Gift I 21,180 97,066
2018-03-01 2018-02-22 4 Hayden Michael R XENE Common Shares G - Gift D -29,580 131,607
2018-02-14 2018-02-12 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) M - Exercise D 3.71 -26,748 0
2018-02-14 2018-02-12 4 COHEN CHARLES J. XENE Common Shares F - Taxes D 3.5000 -22,669 -79 4,079
2018-02-14 2018-02-12 4 COHEN CHARLES J. XENE Common Shares M - Exercise D 3.7100 26,748 99 26,748
2017-11-16 2017-11-15 4 AZAB MOHAMMAD XENE Common Shares P - Purchase D 2.2187 15,000 33 44,210
2017-10-24 2017-10-23 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) A - Award D 3.10 11,000 11,000
2017-10-24 2017-10-23 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 3.10 20,000 20,000
2017-10-24 2017-10-23 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) A - Award D 3.10 11,000 11,000
2017-10-24 2017-10-23 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 3.10 11,000 11,000
2017-10-24 2017-10-23 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 3.10 11,000 11,000
2017-10-24 2017-10-23 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 3.10 25,000 25,000
2017-09-25 2017-09-22 4 AZAB MOHAMMAD XENE Common Shares P - Purchase D 2.9500 8,000 24 29,210
2017-09-25 2017-09-21 4 AZAB MOHAMMAD XENE Common Shares P - Purchase D 2.9500 2,000 6 21,210
2017-08-21 2017-08-18 4 WINQUIST RAYMOND XENE Common Shares P - Purchase D 2.9950 1,000 3 1,000
2017-08-21 2017-08-18 4 AZAB MOHAMMAD XENE Common Shares P - Purchase D 2.8995 6,312 18 19,210
2017-08-21 2017-08-17 4 AZAB MOHAMMAD XENE Common Shares P - Purchase D 2.6500 23 0 12,898
2017-08-17 2017-08-15 4 EMPFIELD JAMES R. XENE Common Shares P - Purchase D 2.4824 10,000 25 10,000
2017-08-16 2017-08-15 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 2.4122 7,429 18 1,077,694
2017-08-16 2017-08-15 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 2.4122 11,429 28 1,674,468
2017-08-16 2017-08-14 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 2.7036 13,337 36 1,070,265
2017-08-16 2017-08-14 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 2.7036 28,007 76 1,663,039
2017-08-15 2017-08-14 4 Svoronos Dawn XENE Common Shares P - Purchase D 2.8154 50,000 141 50,000
2017-08-14 2017-08-11 4 GANNON STEVEN XENE Common Shares P - Purchase D 2.8178 15,000 42 15,000
2017-08-14 2017-08-14 4 Hayden Michael R XENE Common Shares P - Purchase D 2.7498 15,000 41 161,187
2017-08-14 2017-08-10 4 PIMSTONE SIMON N. XENE Common Shares P - Purchase D 2.9000 6,000 17 217,847
2017-08-14 2017-08-10 4 SCHELLER RICHARD H XENE Common Shares P - Purchase D 2.8500 7,000 20 7,000
2017-08-14 2017-08-10 4 MORTIMER IAN By Spouse XENE Common Stock P - Purchase I 2.9000 10,000 29 14,300
2017-08-14 2017-08-10 4 MORTIMER IAN XENE Common Stock P - Purchase D 2.8450 5,000 14 6,000
2017-08-14 2017-08-10 4 PATOU GARY See Note XENE Common Stock P - Purchase I 2.7781 7,500 21 12,500
2017-08-10 2017-08-08 4 PATOU GARY See note XENE Common Stock P - Purchase I 3.0005 5,000 15 5,000
2017-06-30 2017-06-27 4/A BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.0361 8,496 26 297,464
2017-06-30 2017-06-27 4/A BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.0361 30,170 92 1,056,928
2017-06-30 2017-06-27 4/A BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.0361 46,795 142 1,635,032
2017-06-29 2017-06-27 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 8,496 34 297,464
2017-06-29 2017-06-27 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 30,170 121 1,056,928
2017-06-29 2017-06-27 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 46,795 187 1,635,032
2017-06-23 2017-06-22 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 854 3 288,968
2017-06-23 2017-06-22 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 2,884 12 1,026,758
2017-06-23 2017-06-22 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 4,525 18 1,588,237
2017-06-23 2017-06-21 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 1,362 5 288,114
2017-06-23 2017-06-21 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 4,406 18 1,023,874
2017-06-23 2017-06-21 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 4.0000 6,380 26 1,583,712
2017-06-20 2017-06-19 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.51 -1,028 0
2017-06-20 2017-06-19 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -1,028 55,167
2017-06-20 2017-06-19 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.5100 1,028 4 56,195
2017-06-19 2017-06-19 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8500 357 1 286,752
2017-06-19 2017-06-19 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8500 1,271 5 1,019,468
2017-06-19 2017-06-19 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8500 1,967 8 1,577,332
2017-06-19 2017-06-16 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8500 1,064 4 286,395
2017-06-19 2017-06-16 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8500 3,873 15 1,018,197
2017-06-19 2017-06-16 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8500 6,097 23 1,575,365
2017-06-19 2017-06-15 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8370 1,160 4 285,331
2017-06-19 2017-06-15 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8370 3,845 15 1,014,324
2017-06-19 2017-06-15 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8370 6,774 26 1,569,268
2017-06-08 2017-06-07 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8512 20,594 79 284,171
2017-06-08 2017-06-07 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8512 73,749 284 1,010,479
2017-06-08 2017-06-07 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.8512 113,446 437 1,562,494
2017-06-08 2017-06-06 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.7500 913 3 263,577
2017-06-08 2017-06-06 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.7500 53,260 200 936,730
2017-06-08 2017-06-06 4 BVF PARTNERS L P/IL XENE Common Stock, no par value per share P - Purchase D 3.7500 96,736 363 1,449,048
2017-06-02 2017-06-01 4 SCHELLER RICHARD H XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 3.85 1,250 1,250
2017-06-02 2017-06-01 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 Svoronos Dawn XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-06-02 2017-06-01 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 3.85 3,500 3,500
2017-05-16 2017-05-12 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 3.21 -2,057 0
2017-05-16 2017-05-12 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 4.1800 -1,345 -6 4,734
2017-05-16 2017-05-12 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 3.2100 2,057 7 6,079
2017-03-15 2017-03-14 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 3.56 -3,086 0
2017-03-15 2017-03-14 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 3.07 -4,629 0
2017-03-15 2017-03-14 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 3.77 -4,115 0
2017-03-15 2017-03-14 4 Hayden Michael R XENE Stock Option (Right to Buy) M - Exercise D 3.67 -5,144 0
2017-03-15 2017-03-14 4 Hayden Michael R XENE Stock Option (Right to Buy) M - Exercise D 3.76 -25,720 0
2017-03-15 2017-03-14 4 Hayden Michael R XENE Stock Option (Right to Buy) M - Exercise D 3.70 -18,004 0
2017-03-15 2017-03-14 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 3.5600 3,086 11 30,348
2017-03-15 2017-03-14 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 3.0700 4,629 14 27,262
2017-03-15 2017-03-14 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 3.7700 4,115 16 22,633
2017-03-15 2017-03-14 4 Hayden Michael R XENE Common Shares M - Exercise D 3.6700 5,144 19 146,187
2017-03-15 2017-03-14 4 Hayden Michael R XENE Common Shares M - Exercise D 3.7600 25,720 97 141,043
2017-03-15 2017-03-14 4 Hayden Michael R XENE Common Shares M - Exercise D 3.7000 18,004 67 115,323
2017-03-14 2017-03-13 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 8.40 75,000 75,000
2017-03-14 2017-03-13 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 8.40 140,000 140,000
2017-03-14 2017-03-13 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 8.40 27,500 27,500
2017-03-14 2017-03-13 4 WINQUIST RAYMOND XENE Stock Option (Right to Buy) A - Award D 8.40 20,000 20,000
2017-03-14 2017-03-13 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) A - Award D 8.40 20,000 20,000
2017-03-14 2017-03-13 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 8.40 27,500 27,500
2017-03-14 2017-03-13 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) A - Award D 8.40 27,500 27,500
2017-01-27 2017-01-26 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -7,201 55,167
2016-12-19 2016-12-15 4 HOLLER FRANK A XENE Common Shares S - Sale D 7.8500 -30,000 -236 115,869
2016-12-13 2016-12-12 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.21 -14,403 0
2016-12-13 2016-12-12 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -7,202 62,368
2016-12-13 2016-12-12 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.2100 14,403 46 69,570
2016-12-08 2016-12-06 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 3.21 -12,345 0
2016-12-08 2016-12-06 4 PATOU GARY XENE Common Shares F - Taxes D 7.9000 -4,403 -35 12,028
2016-12-08 2016-12-06 4 PATOU GARY XENE Common Shares M - Exercise D 3.2100 12,345 40 16,431
2016-12-02 2016-12-01 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 3.21 -12,345 0
2016-12-02 2016-12-01 4 AZAB MOHAMMAD XENE Common Shares F - Taxes D 7.8000 -4,408 -34 12,875
2016-12-02 2016-12-01 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 3.2100 12,345 40 17,283
2016-09-27 3 Svoronos Dawn XENE No securities are beneficially owned D 0
2016-09-27 2016-09-27 4 Svoronos Dawn XENE Stock Option (Right to Buy) A - Award D 8.15 5,144 5,144
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,381,916
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 3,850,758
2016-09-12 3 LAMPERT MARK N XENE Common Stock, no par value per share D 2,761,110
2016-08-23 2016-08-19 4 HOLLER FRANK A XENE Common Shares S - Sale D 7.6510 -11,938 -91 145,869
2016-08-18 2016-08-18 4 HOLLER FRANK A XENE Common Shares S - Sale D 7.7000 -9,599 -74 157,807
2016-08-18 2016-08-17 4 HOLLER FRANK A XENE Common Shares S - Sale D 7.8900 -1,600 -13 167,406
2016-08-18 2016-08-16 4 HOLLER FRANK A XENE Common Shares S - Sale D 8.2500 -6,863 -57 169,006
2016-08-02 2016-07-29 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 3.30 -12,345 0
2016-08-02 2016-07-29 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 7.4600 -4,703 -35 211,847
2016-08-02 2016-07-29 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 3.3000 12,345 41 216,550
2016-06-28 2016-06-24 4 MORTIMER IAN By spouse XENE Common Stock P - Purchase I 6.3000 1,300 8 4,300
2016-06-28 2016-06-24 4 MORTIMER IAN By spouse XENE Common Stock P - Purchase I 6.2500 2,000 12 3,000
2016-06-28 2016-06-24 4 MORTIMER IAN By spouse XENE Common Stock P - Purchase I 6.1000 1,000 6 1,000
2016-06-28 2016-06-24 4 MORTIMER IAN XENE Common Stock P - Purchase D 6.1500 1,000 6 1,000
2016-06-03 2016-06-02 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-06-03 2016-06-02 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-06-03 2016-06-02 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-06-03 2016-06-02 4 SCHELLER RICHARD H XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-06-03 2016-06-02 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 7.38 1,250 1,250
2016-06-03 2016-06-02 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-06-03 2016-06-02 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-06-03 2016-06-02 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 7.38 3,500 3,500
2016-05-27 2016-05-25 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 3.30 -8,230 0
2016-05-27 2016-05-25 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 3.3000 8,230 27 18,518
2016-04-29 2016-04-28 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 3.35 -1,543 0
2016-04-29 2016-04-28 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -1,543 55,167
2016-04-29 2016-04-28 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 3.3500 1,543 5 56,710
2016-04-04 3 WINQUIST RAYMOND XENE No securities are beneficially owned D 0
2016-04-04 2016-04-04 4 WINQUIST RAYMOND XENE Stock Option (Right to Buy) A - Award D 7.10 35,000 35,000
2016-03-11 2016-03-11 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) A - Award D 7.49 20,000 20,000
2016-03-11 2016-03-11 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 7.49 40,000 40,000
2016-03-11 2016-03-11 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 7.49 20,000 20,000
2016-03-11 2016-03-11 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) A - Award D 7.49 25,000 25,000
2016-03-11 2016-03-11 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 7.49 50,000 50,000
2016-02-09 3 EMPFIELD JAMES R. XENE No securities are beneficially owned D 0
2016-02-09 2016-02-08 4 EMPFIELD JAMES R. XENE Stock Option (Right to Buy) A - Award D 6.76 40,000 40,000
2015-12-21 2015-12-18 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 7.69 15,000 15,000
2015-12-21 2015-12-16 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 5.22 -411 0
2015-12-21 2015-12-16 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 7.9400 -229 -2 4,022
2015-12-21 2015-12-16 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 5.2200 411 2 4,251
2015-12-21 2015-12-18 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 7.69 40,000 40,000
2015-12-21 2015-12-18 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 7.69 25,000 25,000
2015-12-21 2015-12-18 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) A - Award D 7.69 15,000 15,000
2015-12-21 2015-12-18 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) A - Award D 7.69 15,000 15,000
2015-12-14 2015-12-11 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 5.22 2,469 0
2015-12-14 2015-12-11 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 5.2200 2,469 13 4,938
2015-11-25 2015-11-24 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 5.22 -2,057 0
2015-11-25 2015-11-24 4 HOLLER FRANK A XENE Common Shares F - Taxes D 9.3900 -995 -9 175,869
2015-11-25 2015-11-24 4 HOLLER FRANK A XENE Common Shares M - Exercise D 5.2200 2,057 11 176,864
2015-11-06 2015-11-04 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 5.22 -3,497 0
2015-11-06 2015-11-04 4 PATOU GARY XENE Common Shares F - Taxes D 8.3200 -1,955 -16 4,086
2015-11-06 2015-11-04 4 PATOU GARY XENE Common Shares M - Exercise D 5.2200 3,497 18 6,041
2015-11-04 2015-11-02 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 5.22 -5,041 0
2015-11-04 2015-11-02 4 TARNOW MICHAEL M XENE Common Shares G - Gift D -5,041 55,167
2015-11-04 2015-11-02 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 5.2200 5,041 26 60,208
2015-09-24 2015-09-24 4 GOLDBERG Y. PAUL XENE Common Shares S - Sale D 8.6000 -12,000 -103 6,000
2015-09-24 2015-09-23 4 GOLDBERG Y. PAUL XENE Common Shares S - Sale D 9.0200 -4,000 -36 18,000
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 2.68 -785 243
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 2.68 -7,973 4,372
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 3.73 -3,115 1,000
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 3.52 -3,703 0
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 3.56 -6,172 0
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 3.07 -5,144 0
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 3.77 -1,028 0
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 3.21 -2,057 0
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 5.22 -411 0
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares S - Sale D 9.3323 -6,149 -57 22,000
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -167 -2 28,149
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 2.6800 785 2 28,316
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -1,687 -16 27,531
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 2.6800 7,973 21 29,218
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -923 -9 21,245
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 3.7300 3,115 12 22,168
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -1,098 -10 19,053
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 3.5200 3,703 13 20,151
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -1,829 -17 16,448
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 3.5600 6,172 22 18,277
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -1,525 -15 12,105
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 3.0700 5,144 16 13,630
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -305 -3 8,486
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 3.7700 1,028 4 8,791
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -610 -6 7,763
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 3.2100 2,057 7 8,373
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 9.5300 -198 -2 6,316
2015-09-24 2015-09-22 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 5.2200 411 2 6,514
2015-08-20 2015-08-18 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 4.98 -2,057
2015-08-20 2015-08-18 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) M - Exercise D 4.81 -1,028
2015-08-20 2015-08-18 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 11.0000 -868 -10 3,840
2015-08-20 2015-08-18 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 4.9800 2,057 10 4,708
2015-08-20 2015-08-18 4 ROBIN SHERRINGTON XENE Common Shares F - Taxes D 11.0000 -434 -5 2,651
2015-08-20 2015-08-18 4 ROBIN SHERRINGTON XENE Common Shares M - Exercise D 4.8100 1,028 5 3,085
2015-08-20 2015-08-18 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 4.98 -15,432 0
2015-08-20 2015-08-18 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) M - Exercise D 4.81 -5,144 0
2015-08-20 2015-08-18 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 11.0000 -6,508 -72 204,205
2015-08-20 2015-08-18 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 4.9800 15,432 77 210,713
2015-08-20 2015-08-18 4 PIMSTONE SIMON N. XENE Common Shares F - Taxes D 11.0000 -2,170 -24 195,281
2015-08-20 2015-08-18 4 PIMSTONE SIMON N. XENE Common Shares M - Exercise D 4.8100 5,144 25 197,451
2015-08-20 2015-08-18 4 HOLLER FRANK A XENE Stock Option (Right to Buy) M - Exercise D 4.98 -2,057 0
2015-08-20 2015-08-18 4 HOLLER FRANK A XENE Common Shares F - Taxes D 11.0000 -868 -10 174,807
2015-08-20 2015-08-18 4 HOLLER FRANK A XENE Common Shares M - Exercise D 4.9800 2,057 10 175,675
2015-08-20 2015-08-18 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 4.98 -2,057 0
2015-08-20 2015-08-18 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) M - Exercise D 4.81 -1,028 0
2015-08-20 2015-08-18 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 11.0000 -868 -10 6,103
2015-08-20 2015-08-18 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 4.9800 2,057 10 6,971
2015-08-20 2015-08-18 4 GOLDBERG Y. PAUL XENE Common Shares F - Taxes D 11.0000 -434 -5 4,914
2015-08-20 2015-08-18 4 GOLDBERG Y. PAUL XENE Common Shares M - Exercise D 4.8100 1,028 5 5,348
2015-06-19 2015-06-17 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 4.95 -1,543 0
2015-06-19 2015-06-17 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 4.9500 1,543 8 55,167
2015-05-22 3 GANNON STEVEN XENE No securities are beneficially owned D 0
2015-05-22 2015-05-21 4 GANNON STEVEN XENE Stock Option (Right to Buy) A - Award D 12.57 5,144 5,144
2015-05-06 2015-05-04 4 SCHELLER RICHARD H XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-06 2015-05-04 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-06 2015-05-04 4 Evans Johnston L XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-06 2015-05-04 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-06 2015-05-04 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-06 2015-05-04 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 13.48 1,028 1,028
2015-05-06 2015-05-04 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-06 2015-05-04 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 13.48 3,086 3,086
2015-05-04 2015-04-30 4 STEIN EVAN A. XENE Common Shares J - Other I 4,172 4,172
2015-05-04 2015-04-30 4 STEIN EVAN A. XENE Common Shares J - Other I 909,619 910,586
2015-05-04 2015-04-30 4 STEIN EVAN A. XENE Common Shares J - Other I -1,038,964 0
2015-03-19 2015-03-17 4 ROBIN SHERRINGTON XENE Stock Option (Right to Buy) A - Award D 17.76 35,000 35,000
2015-03-19 2015-03-17 4 PIMSTONE SIMON N. XENE Stock Option (Right to Buy) A - Award D 17.76 95,000 95,000
2015-03-19 2015-03-17 4 MORTIMER IAN XENE Stock Option (Right to Buy) A - Award D 17.76 55,000 55,000
2015-03-19 2015-03-17 4 GOLDBERG Y. PAUL XENE Stock Option (Right to Buy) A - Award D 17.76 35,000 35,000
2015-03-19 2015-03-17 4 CORRAINI KAREN G. XENE Stock Option (Right to Buy) A - Award D 17.76 35,000 35,000
2015-03-19 2015-03-17 4 COHEN CHARLES J. XENE Stock Option (Right to Buy) A - Award D 17.76 35,000 35,000
2015-03-18 3 SCHELLER RICHARD H XENE No securities are beneficially owned D 0
2015-03-18 2015-03-16 4 SCHELLER RICHARD H XENE Stock Option (Right to Buy) A - Award D 17.65 5,144 5,144
2015-02-05 2015-02-03 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 4.81 -5,144 0
2015-02-05 2015-02-03 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 4.8100 5,144 25 10,288
2015-01-21 2015-01-07 4/A PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 4.98 -3,497 0
2015-01-21 2015-01-07 4/A PATOU GARY XENE Common Shares F - Taxes D 22.2800 -953 -21 2,544
2015-01-21 2015-01-07 4/A PATOU GARY XENE Common Shares M - Exercise D 4.9800 3,497 17 3,497
2015-01-12 2015-01-08 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) M - Exercise D 4.98 -2,469 0
2015-01-12 2015-01-08 4 AZAB MOHAMMAD XENE Common Shares M - Exercise D 4.9800 2,469 12 2,469
2015-01-12 2015-01-08 4 Hayden Michael R By Genworks Inc. XENE Stock Option (Right to Buy) M - Exercise I 4.98 -5,144 0
2015-01-12 2015-01-08 4 Hayden Michael R By Genworks Inc. XENE Common Shares M - Exercise I 4.9800 5,144 26 5,144
2015-01-12 2015-01-08 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) M - Exercise D 4.98 -5,041 0
2015-01-12 2015-01-08 4 TARNOW MICHAEL M XENE Common Shares M - Exercise D 4.9800 5,041 25 53,624
2015-01-09 2015-01-07 4 PATOU GARY XENE Stock Option (Right to Buy) M - Exercise D 4.98 -3,497 0
2015-01-09 2015-01-07 4 PATOU GARY XENE Common Shares M - Exercise D 4.9800 3,497 17 3,497
2015-01-07 2014-12-31 4 MX Associates, LLP XENE Common Shares J - Other D -17,680 0
2015-01-07 2014-12-31 4 MX Associates, LLP XENE Common Shares J - Other D -85,119 17,680
2015-01-07 2014-12-31 4 MX Associates, LLP XENE Common Shares J - Other D -85,119 17,680
2015-01-07 2014-12-31 4 MX Associates, LLP XENE Common Shares J - Other D -117,456 187,918
2015-01-07 2014-12-31 4 MX Associates, LLP XENE Common Shares J - Other D -1,169,286 305,374
2014-11-25 2014-11-21 4 Bridger Gary XENE Stock Option (Right to Buy) A - Award D 12.65 5,144 5,144
2014-11-12 2014-11-09 4 HOLLER FRANK A XENE Series E Preferred Shares C - Conversion D -2,737 0
2014-11-12 2014-11-09 4 HOLLER FRANK A XENE Series B Preferred Shares C - Conversion D -4,988 0
2014-11-12 2014-11-09 4 HOLLER FRANK A By wife XENE Series A Preferred Shares C - Conversion I -941 0
2014-11-12 2014-11-09 4 HOLLER FRANK A XENE Series A Preferred Shares C - Conversion D -95,002 0
2014-11-12 2014-11-09 4 HOLLER FRANK A By wife XENE Common Shares C - Conversion I 941 1,184
2014-11-12 2014-11-09 4 HOLLER FRANK A XENE Common Shares C - Conversion D 2,737 173,618
2014-11-12 2014-11-09 4 HOLLER FRANK A XENE Common Shares C - Conversion D 4,988 170,881
2014-11-12 2014-11-09 4 HOLLER FRANK A XENE Common Shares C - Conversion D 95,002 165,893
2014-11-12 2014-11-09 4 Evans Johnston L By Invesco Capital Entities XENE Series E Preferred Shares C - Conversion I -444,655 0
2014-11-12 2014-11-09 4 Evans Johnston L By Invesco Capital Entities XENE Common Shares C - Conversion I 444,655 444,655
2014-11-12 2014-11-09 4 Hayden Michael R By wife XENE Series E Preferred Shares C - Conversion I -1,504 0
2014-11-12 2014-11-09 4 Hayden Michael R By wife XENE Series B Preferred Shares C - Conversion I -2,693 0
2014-11-12 2014-11-09 4 Hayden Michael R By wife XENE Series A Preferred Shares C - Conversion I -10,030 0
2014-11-12 2014-11-09 4 Hayden Michael R By wife XENE Common Shares C - Conversion I 1,504 75,886
2014-11-12 2014-11-09 4 Hayden Michael R By wife XENE Common Shares C - Conversion I 2,693 74,382
2014-11-12 2014-11-09 4 Hayden Michael R By wife XENE Common Shares C - Conversion I 10,030 71,689
2014-11-12 2014-11-09 4 TARNOW MICHAEL M XENE Series A Preferred Shares C - Conversion D -16,718 0
2014-11-12 2014-11-09 4 TARNOW MICHAEL M XENE Common Shares C - Conversion D 16,718 48,583
2014-11-12 2014-11-09 4 PIMSTONE SIMON N. XENE Series B Preferred Shares C - Conversion D -1,914 0
2014-11-12 2014-11-09 4 PIMSTONE SIMON N. XENE Series A Preferred Shares C - Conversion D -964 0
2014-11-12 2014-11-09 4 PIMSTONE SIMON N. XENE Common Shares C - Conversion D 1,914 192,307
2014-11-12 2014-11-09 4 PIMSTONE SIMON N. XENE Common Shares C - Conversion D 964 190,393
2014-11-12 2014-11-09 4 STEIN EVAN A. By Lipoterx, Ltd. XENE Series E Preferred Shares C - Conversion I -1,038,964 0
2014-11-12 2014-11-09 4 STEIN EVAN A. By Stein Family LLC XENE Series B Preferred Shares C - Conversion I -967 0
2014-11-12 2014-11-09 4 STEIN EVAN A. By Lipoterx, Ltd. XENE Common Shares C - Conversion I 1,038,964 1,038,964
2014-11-12 2014-11-09 4 STEIN EVAN A. By Stein Family LLC XENE Common Shares C - Conversion I 967 967
2014-11-12 2014-11-09 4 MX Associates, LLP XENE Series E Preferred Shares C - Conversion D -1,474,660 0
2014-11-12 2014-11-09 4 MX Associates, LLP XENE Common Shares C - Conversion D 1,474,660 1,474,660
2014-11-06 3/A HOLLER FRANK A By wife XENE Common Shares I 243
2014-11-06 3/A HOLLER FRANK A XENE Common Shares D 70,891
2014-11-06 2014-11-04 4 TARNOW MICHAEL M XENE Stock Option (Right to Buy) A - Award D 9.00 5,144 5,144
2014-11-06 2014-11-04 4 Hayden Michael R XENE Stock Option (Right to Buy) A - Award D 9.00 5,144 5,144
2014-11-06 2014-11-04 4 AZAB MOHAMMAD XENE Stock Option (Right to Buy) A - Award D 9.00 5,144 5,144
2014-11-06 2014-11-04 4 Evans Johnston L XENE Stock Option (Right to Buy) A - Award D 9.00 5,144 5,144
2014-11-06 2014-11-04 4 PATOU GARY XENE Stock Option (Right to Buy) A - Award D 9.00 5,144 5,144
2014-11-06 2014-11-04 4 STEIN EVAN A. XENE Stock Option (Right to Buy A - Award D 9.00 5,144 5,144
2014-11-06 2014-11-04 4 HOLLER FRANK A XENE Stock Option (Right to Buy) A - Award D 9.00 5,144 5,144
2014-11-04 3 CORRAINI KAREN G. XENE Common Shares D 4,114
2014-11-04 3 CORRAINI KAREN G. XENE Common Shares D 4,114
2014-11-04 3 Hayden Michael R XENE Common Shares D 256,297
2014-11-04 3 Hayden Michael R By wife XENE Common Shares I 220,637
2014-11-04 3 Hayden Michael R XENE Common Shares D 256,297
2014-11-04 3 Hayden Michael R By wife XENE Common Shares I 220,637
2014-11-04 3 TARNOW MICHAEL M XENE Common Shares D 63,730
2014-11-04 3 TARNOW MICHAEL M XENE Common Shares D 63,730
2014-11-04 3 HOLLER FRANK A XENE Common Shares D 142,025
2014-11-04 3 HOLLER FRANK A By wife XENE Common Stock I 71,377
2014-11-04 3 HOLLER FRANK A XENE Common Shares D 142,025
2014-11-04 3 HOLLER FRANK A By wife XENE Common Stock I 71,377
2014-11-04 3 ROBIN SHERRINGTON XENE Common Shares D 4,114
2014-11-04 3 ROBIN SHERRINGTON XENE Common Shares D 4,114
2014-11-04 3 PIMSTONE SIMON N. XENE Common Shares D 395,318
2014-11-04 3 PIMSTONE SIMON N. XENE Common Shares D 395,318
2014-11-04 3 PIMSTONE SIMON N. By wife XENE Common Shares I 222,349
2014-11-04 3 PIMSTONE SIMON N. By wife XENE Common Shares I 222,349
2014-11-04 3 GOLDBERG Y. PAUL XENE Common Shares D 8,640
2014-11-04 3 GOLDBERG Y. PAUL XENE Common Shares D 8,640
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
Other Listings
DE:XP0 € 33.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista